Reported 2026-04-09Lot GT60-042026-199.93% purity · 58.68 mg
Open COA
Lyophilized Peptides
Tirzepatide Research Reference — 60 mg
Catalog material presented by identity, format, availability and applicable lot documentation for qualified laboratory procurement.
CatalogGT-PW-60MG
SourceSee lot documentation
FormatLyophilized Peptides
StatusAvailable
$325.00 Current catalog price; lot availability controls fulfillment.
AvailabilityIn stock
6218 in stock
Current product record, labeling and lot documentation control intended use and handling.
Tirzepatide Research Reference — 60 mg$325.00
01Lot documentationCOA and analytical-record model
02Defined specificationMethod and result remain lot specific
03Tracked fulfillmentShipping method and lot allocation confirmed at order review
04Responsible useNon-clinical laboratory context
Lot documentation
Current Certificate of Analysis
11 approved certificates are attached to this product record.
Reported 2026-04-09Lot GT60-042026-199.93% purity · 58.68 mg
Open COA
Reported 2025-12-22Lot GTP6-12192025-H99.978% purity · 65.54 mg
Open COA
Reported 2025-12-11Lot TIR6012062025-0999.824% purity
Open COA
Reported 2025-12-11Lot FTR6012062025-0999.824% purity · 64.03 mg
Open COA
Reported 2025-12-08Lot GT60-12042025-J99.873% purity
Open COA
Reported 2025-12-08Lot GT60-12042025-J99.873% purity · 62.04 mg
Open COA
Reported 2025-08-13Lot GT60-08112025-J99.84% purity
Open COA
Reported 2025-08-13Lot GT60-08112025-J99.84% purity · 63.01 mg
Open COA
Reported 2025-07-22Lot 6007 182025-05-N99.93% purity
Open COA
Reported 2025-07-22Lot 6007 182025-05-N99.93% purity · 63.72 mg
Open COA
Technical information
Record at a glance
- Primary catalog
- Lyophilized Peptides
- Product type
- Simple product
- Availability
- Available
- Lot control
- Current lot documentation and approved product record control
- Catalog number
- GT-PW-60MG
Intended laboratory context
Illustrative applications
- Evaluation within the lawful context identified by the current product record
- Lot-specific documentation review before procurement or laboratory use
Documentation package
Documentation
- PDFCertificate of Analysis / lot recordSample
- PDFProduct data or handling recordSample
- PDFSupporting product media archiveSample
Intended use, handling, storage and limitations are controlled by the current product record, labeling and applicable lot documentation. No dosing or medical guidance is provided.
Need a current record?
Documentation before decision-making.
Reference GT-PW-60MG and the applicable lot when contacting technical support. Published files support evaluation but do not replace the approved lot COA or material specification.
View documentation model